Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 21509 | 416 | 34.2 | 58% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
| 112 | 3 | CERVICAL CANCER//HUMAN PAPILLOMAVIRUS//GYNECOLOGIC ONCOLOGY | 70812 |
| 185 | 2 | OVARIAN CANCER//GYNECOLOGIC ONCOLOGY//OVARIAN NEOPLASMS | 21857 |
| 21509 | 1 | FUNCTIONING STROMA//51 RNA BINDING PROTEIN S1//ANALYT CHEM PL TOXICOL | 416 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | FUNCTIONING STROMA | authKW | 82573 | 1% | 38% | 3 |
| 2 | 51 RNA BINDING PROTEIN S1 | authKW | 73401 | 0% | 100% | 1 |
| 3 | ANALYT CHEM PL TOXICOL | address | 73401 | 0% | 100% | 1 |
| 4 | ANTISENSE C MYC OLIGONUCLEOTIDE | authKW | 73401 | 0% | 100% | 1 |
| 5 | BEN MAY CANC OBSTET GYNECOL | address | 73401 | 0% | 100% | 1 |
| 6 | BG1 CELLS | authKW | 73401 | 0% | 100% | 1 |
| 7 | BIOCHEM WALLAC | address | 73401 | 0% | 100% | 1 |
| 8 | BIOSTATBIOSTAT BIOINFORMAT CORE | address | 73401 | 0% | 100% | 1 |
| 9 | BOWMAN GRAY MED MED HEMATOL ONCOL | address | 73401 | 0% | 100% | 1 |
| 10 | BOX 4465841 S MARYLAND AVE | address | 73401 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Obstetrics & Gynecology | 9238 | 45% | 0% | 187 |
| 2 | Oncology | 5078 | 57% | 0% | 236 |
| 3 | Endocrinology & Metabolism | 180 | 9% | 0% | 38 |
| 4 | Reproductive Biology | 99 | 3% | 0% | 14 |
| 5 | Pathology | 79 | 5% | 0% | 19 |
| 6 | Geriatrics & Gerontology | 52 | 2% | 0% | 9 |
| 7 | CYTOLOGY & HISTOLOGY | 8 | 0% | 0% | 1 |
| 8 | Medical Laboratory Technology | 7 | 1% | 0% | 4 |
| 9 | Cell Biology | 3 | 4% | 0% | 15 |
| 10 | Medicine, General & Internal | 0 | 2% | 0% | 10 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ANALYT CHEM PL TOXICOL | 73401 | 0% | 100% | 1 |
| 2 | BEN MAY CANC OBSTET GYNECOL | 73401 | 0% | 100% | 1 |
| 3 | BIOCHEM WALLAC | 73401 | 0% | 100% | 1 |
| 4 | BIOSTATBIOSTAT BIOINFORMAT CORE | 73401 | 0% | 100% | 1 |
| 5 | BOWMAN GRAY MED MED HEMATOL ONCOL | 73401 | 0% | 100% | 1 |
| 6 | BOX 4465841 S MARYLAND AVE | 73401 | 0% | 100% | 1 |
| 7 | DF HCC GYNECOL ONCOL GRP | 73401 | 0% | 100% | 1 |
| 8 | EXPT DIAGNOST IMAGING PEDIAT | 73401 | 0% | 100% | 1 |
| 9 | GILLETTE WOMENS ONCOL | 73401 | 0% | 100% | 1 |
| 10 | GYNECOL ANTINEOPLAST PHARMACOL | 73401 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | GYNECOLOGIC ONCOLOGY | 22520 | 14% | 1% | 59 |
| 2 | ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA | 6600 | 6% | 0% | 25 |
| 3 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 5328 | 4% | 0% | 18 |
| 4 | CHINESE JOURNAL OF CANCER | 4636 | 1% | 1% | 5 |
| 5 | JOURNAL OF OVARIAN RESEARCH | 3720 | 1% | 1% | 5 |
| 6 | COMPREHENSIVE ENDOCRINOLOGY | 2222 | 0% | 3% | 1 |
| 7 | ENDOCRINE-RELATED CANCER | 2165 | 2% | 0% | 7 |
| 8 | OBSTETRICS AND GYNECOLOGY | 1308 | 4% | 0% | 16 |
| 9 | MATURITAS | 995 | 2% | 0% | 7 |
| 10 | FOLIA HISTOCHEMICA ET CYTOCHEMICA | 872 | 0% | 1% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | SCAMBIA, G , FERRANDINA, G , D'AGOSTINO, G , FAGOTTI, A , DI STEFANO, M , FANFANI, F , SERRI, FG , MANCUSO, S , (1998) OESTROGEN AND PROGESTERONE RECEPTORS IN OVARIAN CARCINOMA.ENDOCRINE-RELATED CANCER. VOL. 5. ISSUE 4. P. 293 -301 | 53 | 91% | 7 |
| 2 | RAO, BR , SLOTMAN, BJ , (1991) ENDOCRINE FACTORS IN COMMON EPITHELIAL OVARIAN-CANCER.ENDOCRINE REVIEWS. VOL. 12. ISSUE 1. P. 14-26 | 75 | 59% | 174 |
| 3 | RAO, BR , SLOTMAN, BJ , (1996) ENDOCRINE ROLE IN OVARIAN CANCER.ENDOCRINE-RELATED CANCER. VOL. 3. ISSUE 4. P. 309-326 | 74 | 56% | 12 |
| 4 | MODUGNO, F , LASKEY, R , SMITH, AL , ANDERSEN, CL , HALUSKA, P , OESTERREICH, S , (2012) HORMONE RESPONSE IN OVARIAN CANCER: TIME TO RECONSIDER AS A CLINICAL TARGET?.ENDOCRINE-RELATED CANCER. VOL. 19. ISSUE 6. P. R255 -R279 | 67 | 32% | 28 |
| 5 | SALLUM, LF , SARIAN, LO , ANDRADE, LLD , VASSALLO, J , SOARES, FA , PINTO, GA , FERREIRA, PA , DERCHAIN, S , (2013) SURVIVAL OF WOMEN WITH OVARIAN CARCINOMAS AND BORDERLINE TUMORS IS NOT AFFECTED BY ESTROGEN AND PROGESTERONE RECEPTOR STATUS.JOURNAL OF GYNECOLOGIC ONCOLOGY. VOL. 24. ISSUE 2. P. 167-176 | 19 | 86% | 5 |
| 6 | SERKIES, K , SINACKI, M , JASSEM, J , (2013) THE ROLE OF HORMONAL FACTORS AND ENDOCRINE THERAPY IN OVARIAN CANCER.WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY. VOL. 17. ISSUE 1. P. 14-19 | 27 | 56% | 2 |
| 7 | MAKAR, AP , (2000) HORMONE THERAPY IN EPITHELIAL OVARIAN CANCER.ENDOCRINE-RELATED CANCER. VOL. 7. ISSUE 2. P. 85 -93 | 35 | 52% | 46 |
| 8 | TANGJITGAMOL, S , MANUSIRIVITHAYA, S , KHUNNARONG, J , JESADAPATARAKUL, S , TANWANICH, S , (2009) EXPRESSIONS OF ESTROGEN AND PROGESTERONE RECEPTORS IN EPITHELIAL OVARIAN CANCER A CLINICOPATHOLOGIC STUDY.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. VOL. 19. ISSUE 4. P. 620-627 | 18 | 78% | 25 |
| 9 | SIMPKINS, F , GARCIA-SOTO, A , SLINGERLAND, J , (2013) NEW INSIGHTS ON THE ROLE OF HORMONAL THERAPY IN OVARIAN CANCER.STEROIDS. VOL. 78. ISSUE 6. P. 530-537 | 35 | 35% | 14 |
| 10 | AHLGREN, JD , ELLISON, NM , GOTTLIEB, RJ , LALUNA, F , LOKICH, JJ , SINCLAIR, PR , UENO, W , WAMPLER, GL , YEUNG, KY , ALT, D , ET AL (1993) HORMONAL PALLIATION OF CHEMORESISTANT OVARIAN-CANCER - 3 CONSECUTIVE PHASE-II TRIALS OF THE MID-ATLANTIC ONCOLOGY PROGRAM.JOURNAL OF CLINICAL ONCOLOGY. VOL. 11. ISSUE 10. P. 1957-1968 | 36 | 56% | 84 |
Classes with closest relation at Level 1 |